Arjo AB (publ) (FRA:A39)

Germany flag Germany · Delayed Price · Currency is EUR
2.818
-0.040 (-1.40%)
At close: Jun 5, 2025, 10:00 PM CET
-28.84%
Market Cap 785.27M
Revenue (ttm) 1.05B
Net Income (ttm) 42.12M
Shares Out n/a
EPS (ttm) 0.15
PE Ratio 18.64
Forward PE 13.18
Dividend 0.09 (3.20%)
Ex-Dividend Date Apr 30, 2025
Volume 49
Average Volume 100
Open 2.818
Previous Close 2.858
Day's Range 2.818 - 2.818
52-Week Range 2.662 - 4.028
Beta n/a
RSI 40.19
Earnings Date Jul 11, 2025

About Arjo AB

Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia care, bariatric room solutions, prone positioning, early mobili... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 1957
Employees 7,173
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol A39
Full Company Profile

Financial Performance

In 2024, Arjo AB's revenue was 11.29 billion, an increase of 2.84% compared to the previous year's 10.98 billion. Earnings were 498.00 million, an increase of 3.75%.

Financial numbers in SEK Financial Statements

News

There is no news available yet.